Zoetis Inc. (ZTS) - Stock Analysis

Zoetis Inc. Financial Analysis

Current Price: $77.59 +1.58%

Market Cap: $32.53B

Sector: Healthcare

P/E Ratio: 20.87

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or

Report Contents

  • Income Statement Analysis (5-year history)
  • Balance Sheet Overview
  • Cash Flow Statement
  • Key Financial Ratios
  • Valuation Metrics (P/E, EV/EBITDA, P/S)
  • Peer Comparison
  • Revenue & Earnings Growth Trends
  • Margin Analysis
  • Analyst Price Targets
  • DCF Valuation Model